Atara Biotherapeutics: T-Cell Therapy Developer With Late-Stage Candidate In Rare DiseaseSeeking Alpha • 05/13/19
Atara Biotherapeutics, Inc. (ATRA) CEO Isaac Ciechanover on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/12/19